Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2021 1
2022 3
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
The Impact of Hyaluronan on Tumor Progression in Cutaneous Melanoma.
Takabe P, Siiskonen H, Rönkä A, Kainulainen K, Pasonen-Seppänen S. Takabe P, et al. Among authors: ronka a. Front Oncol. 2022 Jan 21;11:811434. doi: 10.3389/fonc.2021.811434. eCollection 2021. Front Oncol. 2022. PMID: 35127523 Free PMC article. Review.
The prognostic and predictive role of tumor-infiltrating lymphocytes (FoxP3 + and CD8 +) and tumor-associated macrophages in early HER2 + breast cancer.
Jääskeläinen MM, Tiainen S, Siiskonen H, Ahtiainen M, Kuopio T, Rönkä A, Kettunen T, Hämäläinen K, Rilla K, Harvima I, Mannermaa A, Auvinen P. Jääskeläinen MM, et al. Among authors: ronka a. Breast Cancer Res Treat. 2023 Sep;201(2):183-192. doi: 10.1007/s10549-023-07017-8. Epub 2023 Jul 10. Breast Cancer Res Treat. 2023. PMID: 37428418 Free PMC article.
Survival of patients with mantle cell lymphoma in the rituximab era: Retrospective binational analysis between 2000 and 2020.
Harmanen M, Hujo M, Sund R, Sorigue M, Khan M, Prusila R, Klaavuniemi T, Kari E, Jantunen E, Sunela K, Rajamäki A, Alanne E, Kuitunen H, Sancho JM, Jukkola A, Rönkä A, Kuittinen O. Harmanen M, et al. Among authors: ronka a. Br J Haematol. 2023 Apr;201(1):64-74. doi: 10.1111/bjh.18597. Epub 2022 Dec 13. Br J Haematol. 2023. PMID: 36513500
Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria.
Harmanen M, Klaavuniemi T, Sorigue M, Khan M, Prusila R, Kari E, Alanne E, Rajamäki A, Sunela K, Jukkola A, Jantunen E, Sancho JM, Ketola S, Kuitunen H, Selander T, Rönkä A, Kuittinen O. Harmanen M, et al. Among authors: ronka a. Hemasphere. 2023 Sep 7;7(10):e954. doi: 10.1097/HS9.0000000000000954. eCollection 2023 Oct. Hemasphere. 2023. PMID: 37693119 Free PMC article. No abstract available.
Blood-Brain Barrier Disruption (BBBD)-Based Immunochemotherapy for Primary Central Nervous System Lymphoma (PCNSL), Early Results of a Phase II Study.
Kuitunen HK, Rönkä ALK, Sonkajärvi EM, Isokangas JM, Pyörälä M, Palosaari KAA, Jokimäki AS, Partanen AE, Littow HJ, Vakkala MA, Jantunen EJ, Huttunen ME, Marin KJ, Aromaa-Häyhä AMK, Auvinen PK, Selander T, Puhakka IK, Kuittinen OM. Kuitunen HK, et al. Among authors: ronka alk. Cancers (Basel). 2023 Feb 20;15(4):1341. doi: 10.3390/cancers15041341. Cancers (Basel). 2023. PMID: 36831682 Free PMC article.
Antibiotic Treatment is an Independent Poor Risk Factor in NSCLC But Not in Melanoma Patients Who had Received Anti-PD-1/L1 Monotherapy.
Vihinen H, Jokinen A, Laajala TD, Wahid N, Peltola L, Kettunen T, Rönkä A, Tiainen L, Skyttä T, Kohtamäki L, Tulokas S, Karhapää H, Hernberg M, Silvoniemi M, Mattila KE. Vihinen H, et al. Among authors: ronka a. Clin Lung Cancer. 2023 Jun;24(4):295-304. doi: 10.1016/j.cllc.2023.01.004. Epub 2023 Jan 24. Clin Lung Cancer. 2023. PMID: 36774235 Free article.
13 results